SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-200720
Filing Date
2012-05-01
Accepted
2012-05-01 16:06:48
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d334788d10q.htm 10-Q 311155
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d334788dex311.htm EX-31.1 9900
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d334788dex312.htm EX-31.2 9926
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 d334788dex321.htm EX-32.1 3586
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 d334788dex322.htm EX-32.2 3466
  Complete submission text file 0001193125-12-200720.txt   1414012

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chtp-20120331.xml EX-101.INS 108135
7 XBRL TAXONOMY EXTENSION SCHEMA chtp-20120331.xsd EX-101.SCH 13371
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20120331_cal.xml EX-101.CAL 27058
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20120331_def.xml EX-101.DEF 8801
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20120331_lab.xml EX-101.LAB 114708
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20120331_pre.xml EX-101.PRE 79445
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 12800670
SIC: 2836 Biological Products, (No Diagnostic Substances)